Lysozyme, a mediator of sepsis that deposits in the systemic vasculature and kidney as a possible mechanism of acute organ dysfunction

Shock

Volumn 41, Issue 3, 2014, Pages 256-265

  Gotes, Jose ^a,b   Kasian, Krika ^b   Jacobs, Hans ^b   Cheng, Zhao Qin ^b   Mink, Steven N ^b  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

ethyl gallate; Hydrogen peroxide signaling; hypotension; kidney injury; renal failure; vascular protein deposition

Indexed keywords

ANIMALS; AORTA; CAROTID ARTERIES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOGS; HUMANS; INTESTINE, SMALL; KIDNEY TUBULES, DISTAL; MACROPHAGES; MESENTERIC ARTERIES; MURAMIDASE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; ORGAN CULTURE TECHNIQUES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SEPSIS;

EID: 84894479784     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000095     Document Type: Article

References (32)

1. Fry DE: Sepsis, systemic inflammatory response, and multiple organ dysfunction: the mystery continues. Am Surg 78:1-8, 2012.
2. Hotchkiss RS, Karl I: The pathophysiology and treatment of sepsis. N Engl J Med 348:138-148, 2003.
3. Briggs RS, Perillie PE, Finch SC: Lysozyme in bone marrow and peripheral blood cells. J Histochem Cytochem 14:167-170, 1969.
4. Burgess P, Appel SH, Wilson CA, Polk HC Jr: Detection of intra-abdominal abscess by serum lysozyme estimation. Surgery 115:16-21, 1994.
5. Gotes J, Jacobs H, Kasian K, Cheng Z-Q, Mink SN: Mechanisms of systemic vasodilation by lysozyme-c in septic shock. J Appl Physiol 112:638-650, 2012.
6. Jacobs H, Mink SN, Duke K, Bose D, Cheng ZQ, Howlett S, Ferrier GR, Light RB: Characterization of membrane N-glycan binding sites of lysozyme for cardiac depression in sepsis. Intensive Care Med 31:129-137, 2005.
7. Mink SN, Bose R, Roberts DE, Jacobs H, Duke K, Bose D, Cheng ZQ, Light RB: Lysozyme binding to endocardial endothelium mediates myocardial depression by the nitric-oxide guanosine 3¶,5¶ monophosphate pathway in sepsis. J Mol Cell Cardiol 39:615-625, 2005.
8. Mink SN, Jacobs H, Bose D, Duke K, Cheng ZQ, Liu G, Light RB: Lysozyme: a mediator of myocardial depression and adrenergic dysfunction in septic shock in dogs. J Mol Cell Cardiol 35:265-275, 2003.
9. Mink SN, Jacobs H, Cheng ZQ, Kasian K, Santos-Martinez E, Light RB: Lysozyme, a mediator of sepsis that intrinsically generates hydrogen peroxide to cause cardiovascular dysfunction. Am J Physiol Heart Circ Physiol 297: H930-H948, 2009.
10. Mink SN, Jacobs H, Duke K, Bose D, Cheng ZQ, Light RB: N,N¶,Nμ triacetylglucosamine, an inhibitor of lysozyme, prevents myocardial depression in E. coli sepsis in dogs. Crit Care Med 32:184-193, 2004.
11. Mink SN, Jacobs H, Gotes J, Kasian K, Cheng ZQ: Ethyl-gallate, a scavenger of hydrogen peroxide that inhibits lysozyme-induced hydrogen peroxide signaling in vitro, reverses hypotension in canine septic shock. J Appl Physiol 110:359-374, 2011.
12. Mink SN, Kasian K, Santos-Martinez LEF, Jacobs H, Bose R, Chen Z-Q, Light RB: Lysozyme, a mediator of sepsis that produces vasodilation by hydrogen peroxide signaling in an arterial preparation. Am J Physiol Heart Circ Physiol 294:H1724-H1735, 2008.
13. Mink SN, Kasian K, Jacobs H, Cheng ZQ, Light RB: N,N¶- diacetylchitobiose, an inhibitor of lysozyme, reverses myocardial depression and lessens norepinephrine requirements in Escherichia coli sepsis in dogs. Shock 29:681-687, 2008.
14. Fleming A: On a remarkable bacteriolytic element found in tissue and secretions. Proc R Soc Lond (Biol) 93:306-307, 1922.
15. Wentworth AD, Jones LH, Wentworth P Jr, Janda KD, Lerner RA: Antibodies have the intrinsic capacity to destroy antigens. Proc Natl Acad Sci 97: 10930-10935, 2000.
16. Wentworth P Jr, Jones LH, Wentworth AD, Zhu X, Larsen NA, Wilson IA, Xu X, Goddard WA, Janda KD, Eschenmoser A, et al.: Antibody catalysis of the oxidation of water. Science 293:1806-1811, 2001.
17. Wentworth P, Wentworth AD, Zhu X, Wilson IA, Janda KD, Eschenmoser A, Lerner RA: Evidence for the production of trioxygen species during antibodycatalyzed chemical modification of antigens. Proc Natl Acad Sci USA 100: 1490-1493, 2003.
18. National Institutes of Health: Guide for the Care and Use of Laboratory Animals. Bethesda, MD: National Institutes of Health, 1996.
19. Shugar D: Measurement of lysozyme activity and the ultra violet inactivation of lysozyme. Biochim Biophys Acta 8:302-309, 1952.
20. Gotes J, Jacobs H, Kasian K, Cheng Z-Q, Mink SN: Benefits of ethyl-gallate vs. norepinephrine on hemodynamics in experimental septic shock in dogs. Crit Care Med 40:560-572, 2012.
21. Gomez A, Unruh H, Mink SN: Altered left ventricular chamber stiffness and isovolumic relaxation in dogs with chronic pulmonary hypertension caused by emphysema. Circulation 87:247-260, 1993.
22. Gericke A, Martinka R, Nazarenko I, Persson PB, Patzak A: Impact of !1- adrenoceptor expression on contractile properties of vascular smooth muscle cells. Am J Physiol Regul Integr Comp Physiol 293:R1215-R1221, 2007.
23. Hsieh TJ, Liu TZ, Chia YC, Chern Cl Lu FJ, Chuang MC, Mau SY, Chen SH, Syu YH, Chen CH: Protective effect of methyl gallate from Toona sinensis (Meliaceae) against hydrogen peroxideYinduced oxidative stress and DNA damage in MDCK cells. Food Chem Toxicol 42:843-850, 2004.
24. Basnayake K, Ying WA, Wang PW, Sanders PW: Immunoglobulin light chains activate tubular epithelial cells through redox signaling. J Am Soc Neprhol 21:1165-1173, 2010.
25. Wang PX, Sanders PW: Immunoglobulin light chains generate hydrogen peroxide. J Am Soc Nephrol 18:1239-1245, 2007.
26. Ying WZ, Wang PX, Aaron KJ, Basnayake K, Sanders PW: Immunoglobulin light chains activate nuclear factor-.B in renal epithelial cells through a Srcdependent mechanism. Blood 117:1301-1307, 2011.
27. Ying WZ, Wang PX, Sanders PW: Pivotal role of apoptosis signal-regulating kinase 1 in monoclonal free light chainYmediated apoptosis. Am J Path 180: 41-47, 2012.
28. Gorbenko G, Trusova V: Effects of oligomeric lysozyme on structural state of model membranes. Biophys Chem 154:73-81, 2011.
29. Trusova V: Modulation of physiological and pathological activities of lysozyme by biological membranes. Cell Mol Biol Lett 17:349-375, 2012.
30. Maack T, Duncan D, Mackensie S, Kinter W: Intracellular pathways of renal reabsorpton of lysozyme. Am J Physiol 221:1609-1616, 1971.
31. Hysing J, Tolleshaug H: Quantitative aspects of the uptake and degradation of lysozyme in the rat kidney in vivo. Biochim Biophys Acta 887:42-50, 1986.
32. Patel TV, Rennke HG, Sloan JM, DeAngelo DJ, Charytan DM: A forgotten cause of kidney injury in chronic myelomonocytic leukemia. Am J Kidney Dis 54:159-164, 2009.